Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice

We assessed the efficacy of simultaneous agonism at the glucagon-like peptide-1 receptor (GLP-1R) and the melanocortin-4 receptor (MC4R) for the treatment of obesity and diabetes in rodents. Diet-induced obese (DIO) mice were chronically treated with either the long-acting GLP-1R agonist liraglutide...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:EMBO Mol Med
Päätekijät: Clemmensen, Christoffer, Finan, Brian, Fischer, Katrin, Tom, Robby Zachariah, Legutko, Beata, Sehrer, Laura, Heine, Daniela, Grassl, Niklas, Meyer, Carola W, Henderson, Bart, Hofmann, Susanna M, Tschöp, Matthias H, Van der Ploeg, Lex HT, Müller, Timo D
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BlackWell Publishing Ltd 2015
Aiheet:
Research Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364946/
https://ncbi.nlm.nih.gov/pubmed/25652173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201404508
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia